Original Research
Published on 19 Jul 2024
Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
in Renal Endocrinology
![Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial](https://www.frontiersin.org/files/myhome article library/1387993/1387993_Thumb_400.jpg)
- 198 views